KS

Kyasapura Shankarmurthy Lingaraju

Active Director Director DIN 09164675
DIN 09164675 First appointment May 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Kyasapura Shankarmurthy Lingaraju

Data last updated:

Kyasapura Shankarmurthy Lingaraju is a Director at Ralincare Lifesciences Private Limited (since 2021). The company operates in Pharma.

DIN 09164675
Primary Designation Director
Industry Pharma
First Appointment 04 May 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 May 20212021Active

Board colleagues of Kyasapura Shankarmurthy Lingaraju

NameDINCompanyDesignation
Rajendrakumarn Shah08844798Ralincare Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ralincare Lifesciences Private Limited
Premium access

Shareholding and investment profile for Kyasapura Shankarmurthy Lingaraju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kyasapura Shankarmurthy Lingaraju

Kyasapura Shankarmurthy Lingaraju currently holds 1 directorship: Ralincare Lifesciences Private Limited (Director, since 04 May 2021).

Kyasapura Shankarmurthy Lingaraju was first appointed on 04 May 2021 as Director at Ralincare Lifesciences Private Limited.

The current boards of Kyasapura Shankarmurthy Lingaraju's companies include Rajendrakumarn Shah (Ralincare Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available